ATRX and astrocytoma (excluding glioblastoma): Among grade 2 and 3 astrocytomas, a few cases showed IDH1 negativity (42.1% and 33.3%, respectively), and a few of them showed retained ATRX (78.9% and 66.7%, respectively).